Walsh & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$105K Hold
250
– – 0.08% 85
2026
Q2
$90.5K Hold
250
– – 0.07% 93
2026
Q1
$88K Hold
250
– – 0.09% 87
2025
Q4
$81.8K Hold
250
– – 0.08% 87

Other funds holding AMGN

Walsh & Associates's AMGN Position: Q3 2026 in Review

Walsh & Associates held its Amgen (AMGN) position steady in Q3 2026 at 250 shares worth $105K. The position accounts for 0.08% of the portfolio, ranked #85.

Walsh & Associates first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Walsh & Associates held 250 shares of Amgen worth $105K as of Q3 2026.
  • Walsh & Associates left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.08% of Walsh & Associates's portfolio in Q3 2026, its #85 holding.
  • Walsh & Associates first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.